1. Market Research
  2. > Healthcare Market Trends
  3. > Diagnostics

Medical Diagnostics Industry Overview: Latest Market Reports & Studies

  • Currently 3/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
41 votes

More market segments:

Global Diagnostics Industry

The diagnostics industry involves testing patients to detect disease. Diagnosis can be used in the case of patients already presenting symptoms of disease, to screen asymptomatic patients as a matter of routine, and to allow ongoing testing in patients with disease to establish prognosis or check progress of therapy. The section is part of the wider healthcare industry.

The market can be broadly divided into:

  1. In vitro diagnostics (IVD), which refers to testing samples of blood, tissue, for example electrocardiography; and
  2. Diagnostic imaging, such as x-rays, computerized axial tomography (CAT), mammograms and magnetic resonance imaging (MRI).

Leading Market Segment

The IVD market, estimated at $44 billion in 2010, is predicted to reach $52 billion by 2013 with a compound annual grown rate of approximately 5%, according to research from RNCOS. A particularly profitable growth sector within IVD, molecular diagnostics is predicted to reach $15 billion by 2014 at a compound annual growth rate of just under 20% reports Renub Research. Infectious diseases account for more than a fifth of this segment, followed by oncology testing. By 2014 blood testing and genetic screening together will account for over a quarter of the market, with the US representing $6 billion of the molecular diagnostics market by that time.

Blood grouping reagent Export

Diagnostics Industry Regional Market Share

The In Vitro Diagnostic market is dominated by the US and the EU, which combined comprise about three quarters of the global market. This is because developed countries are witnessing a proliferation of diet and lifestyle related diseases such as cancer, diabetes and cardiovascular disease, whereas developing countries are more concerned with the diagnosis of infection and infectious disease.

In the lead, the IVD market in the US is forecast to grow 5.4% annually, reaching $23 billion in 2013. According to Global Industry Analysts, the US molecular diagnostics market will be over $6.35 billion by 2015.

Following behind, the EU represents the second-largest regional market, with its infectious-disease testing market estimated to reach $1.02 billion in 2012. There is strong growth in oncology testing and pharmacogenomics, which are predicted to show a compound annual growth rate of 10.71% and 11.05%, respectively, between 2011 and 2015.

Top 3 Medical Diagnostics Players

Roche is the market leader in IVD, holding approximately 20% of total market share, followed by Abbott and Siemens, each holding more than 10%.

Roche’s 20% market share represents yearly sales of $44 billion, with key products such as CoaguChek and Accu-Chek fueling the company’s growth. Roche saw 20% growth in Asia-Pacific alone and a 5% rise in the US. Acquisitions, such as in diabetes care (Medingo Ltd) and tissue diagnostics (Biolmagene Inc), should see continued market growth for Roche going forward.

In business for over 120 years, Abbott's sales in 2010 reached over $35 billion, and it invested $3.7 billion in R&D. Its main area of expertise in diagnostics is immunodiagnostics. Abbott's immunoassay diagnostic systems, AxSYM, is used to test for cardiovascular disease, cancer, infectious diseases and thyroid conditions.

Read more »

Customer Support

Talk to Sam

+852 5808 2421

140 Reports
Company, Demand, Market Description
960 Statistics
Market Size, Finance, Company Financials
630 Reports
Company Financials, Supply, Company
1800 Statistics
Market Size, Finance, Company Financials
21 Reports
Demand, Market Size, Company
430 Statistics
Market Size, Demand, Finance
15 Reports
Demand, Company Financials, Market Size
160 Statistics
Market Size, Finance, Company Financials
49 Reports
Demographic, Demand, Supply
220 Statistics
Demographic, Environment, Finance
20 Reports
Company Financials, Company, Market Size
180 Statistics
Market Size, Finance, Company Financials
24 Reports
Company Financials, Company, Supply
160 Statistics
Finance, Company Financials, Market Size
26 Reports
Company Financials, Demand, Company
90 Statistics
Company, Finance, Company Financials
6 Reports
Company Financials, Supply, Market Size
83 Statistics
Finance, Company Financials, Company
11 Reports
Social Conditions, Demand, M&A
10 Statistics
Demographic, Market Size, Supply

About 7000 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 149 - $ 54500)

A 33-Country Survey of the Infectious Disease Testing Market 2017-2022: Country Market Shares, Sales&Volume Forecasts for 100 Microbiology Tests, Competitive Strategies, Instrumentation Review, Emerging Technologies, Opportunities for Suppliers

A 33-Country Survey of the Infectious Disease Testing Market 2017-2022: Country Market Shares, Sales&Volume Forecasts for 100 Microbiology Tests, Competitive Strategies, Instrumentation Review, Emerging Technologies, Opportunities for Suppliers

  • $ 54500
  • Industry report
  • January 2018
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

A 33-Country Survey of the Cancer Diagnostic Testing Ma ... $ 47400 January 2018

Cancer Diagnostics 2021: Supplier Shares and Market Seg ... $ 24500 October 2017

2021 Tumor Markers 2021: Unlocking Mystery of the Genet ... $ 24500 October 2017

2018-2022 Microbiology Analyzers and Consumables: US, E ... $ 22400 January 2018

Global Automated Microbiology Market Country Shares and ... $ 22400 January 2018

Global Automated Microbiology Market Forecasts 2017-202 ... $ 22400 December 2017

Pharmaceutical, Laboratory and Hygienic Glassware Marke ... $ 26587 January 2018

2018 Global Cancer Diagnostics Market Segmentation Anal ... $ 21100 June 2018

2018 Global Cancer Diagnostics Market: US, Europe, Japa ... $ 21100 June 2018


ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on